Allison Meads

Allison Meads serves as a key procurement professional within the FDA Office of Acquisition and Grant Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific and technical services. She manages a portfolio focused on high-precision analytical instrumentation, laboratory infrastructure, and research support contracts essential to regulatory science. Her work ensures the FDA maintains cutting-edge capabilities in drug safety evaluation, biomedical research, and medical device testing, aligning procurement activities with the agency’s scientific priorities and compliance requirements. Meads maintains consistent working relationships with specialized contractors including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc, and Progenics Pharmaceuticals Inc, all of which provide niche scientific, clinical, and laboratory support services. These partnerships reflect a preference for vendors with deep domain expertise in toxicology, clinical trial support, and pharmaceutical research, enabling the FDA to execute complex regulatory evaluations with scientific rigor and operational efficiency. Her procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition, indicating a focus on technical capability and mission-critical performance over socioeconomic preferences. This approach prioritizes access to the most qualified technical resources, regardless of business size or certification status, to meet the FDA’s stringent scientific and regulatory demands. The primary NAICS classification under her purview is 541519 (Other Computer Related Services), reflecting a strong emphasis on bioinformatics, data analysis platforms, computational modeling, and digital laboratory systems. She procures advanced software solutions, data management tools, and specialized IT services that underpin the agency’s regulatory science initiatives, demonstrating expertise in integrating technology with biomedical research workflows to enhance decision-making and public health outcomes.